Universitaetsklinikum Heidelberg AöR

Heidelberg 69120

3 studies enrolling now · 3 studies all time

What they study most

Locally Advanced Cutaneous Squamous Cell Carcinoma, Melanoma, Cutaneous Malignant, Multiple Myeloma

Studies at this site

• L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma — Recruiting now
• SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma — Recruiting now
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now